Medindia LOGIN REGISTER
Medindia

Sun Pharma Gets Green Signal from FDA for Wellbutrin

by Rajshri on Apr 8 2010 9:52 PM

Indian drugmaker Sun Pharmaceuticals has announced that it has got approval from the U.S. regulatory authorities to market a generic version of GlaxoSmithKline's Wellbutrin SR extended release tablets.

The company, which is in trouble in Israel, said that the FDA approved its application to market a generic version of Wellbutrin on Thursday.

Wellbutrin is an antidepressant medication and works in the brain to treat major depressive disorder and seasonal affective disorder


Source-Medindia
RAS


Advertisement